Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $10.19, but opened at $10.64. Anbio Biotechnology shares last traded at $10.7250, with a volume of 759 shares.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The business’s 50 day simple moving average is $12.86.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.